You will find that our Sofdra product may be used by other patients for other hypersecretory issues and doctors might also be recommending it for an off label use. Can only hope and look what happened with ozempic.
Two per cent you say? Shoot for the sky and hit the roof is better than shooting for the ceiling and hitting the floor.
Not long now as we seek a Washington poltician with a very slim margin to help us advertise the product. He or she would be sweating unless they are from California or Florida then they're safe.
You will find that our Sofdra product may be used by other...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.020(6.45%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 33.5¢ | 30.5¢ | $2.848M | 8.878M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24615 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 105525 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
0.020 ( 6.73 %) |
||||
| Open | High | Low | Volume | ||
| 31.0¢ | 33.5¢ | 30.8¢ | 3931977 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| BOT (ASX) Chart |